Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2002, p. 3251-3260, Vol. 68, No. 7
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.7.3251-3260.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Center for Ultrastructure Research and Ludwig Boltzmann-Institute for Molecular Nanotechnology, University of Agricultural Sciences, 1180 Vienna, Austria
Received 12 December 2001/ Accepted 19 April 2002
|
|
|---|
|
|
|---|
S-layers are unique biomaterials with properties most relevant for applications in molecular nanotechnology, nanobiotechnology, and biomimetics (38). Many S-layer proteins recrystallize into regularly structured monolayers on solid supports, such as silicon wafers, gold chips, and silanized glass or plastic materials, as well as on Langmuir lipid films, on liposomes (20, 23), and at the air-water interface. Pores passing through S-layer lattices are of identical size and morphology, and functional groups show a regular distribution and high density. For production of S-layer-based biosensors (38), affinity microparticles (45), and solid-phase immunoassays (3, 4, 39), functional groups in the S-layer lattice were exploited as covalent binding sites for biologically active macromolecules, such as enzymes, antibodies, or ligands. As alternatives to the existing technology, namely, immobilization by chemical methods, genetic approaches are particularly attractive for incorporation of functional peptide sequences into S-layer proteins, which must be done at positions that do not interfere with their self-assembly properties and their interaction with SCWP. To guarantee that the integrated or fused functional sequence remains located on the outer surface of the S-layer lattice and available for further binding reactions, the specific interactions with the SCWP shall be exploited in future developments to achieve an oriented binding of S-layer fusion proteins on artificial supports. The concept of generating oriented functional protein lattices implies that SCWPs are attached to solid supports or that appropriate glycolipids comprising the smallest functional units of SCWPs are synthesized and incorporated into liposomes or Langmuir lipid films (Fig. 1).
![]() View larger version (44K): [in a new window] |
FIG. 1. Schematic drawing showing the formation of oriented functional S-layer lattices on peptidoglycan-containing sacculi and artificial supports coated with secondary cell wall polymer. In the case of peptidoglycan-containing sacculi, only the outer S-layer is shown.
|
3)-[4,6-O-(1-carboxyethylidene)]
0.5-ß-D-ManpNAc-(1
4)-ß-D-GlcpNAc-(1
as a binding site in the rigid cell wall layer. The polymer chains consist of eight or nine disaccharide repeating units, and they are covalently linked to the peptidoglycan backbone (13). So far, the genes encoding the S-layer proteins of B. sphaericus P-1 (6) and B. sphaericus 2362 (1) have been cloned and sequenced. In the present study, the sbpA gene, encoding the S-layer protein of B. sphaericus CCM 2177, was sequenced, cloned, and expressed in Escherichia coli. Furthermore, the accessibility of the C-terminal amino acids of the recombinant S-layer protein (rSbpA) and a C-terminally truncated form (rSbpA31-1068) was investigated by fusion of the sequence encoding the short affinity peptide Strep-tag I (AWRHPQFGG) (36) to the sequences of the appropriate S-layer gene forms. Strep-tag I confers binding activity towards streptavidin and Strep-Tactin. The latter is a genetically modified streptavidin with increased affinity to Strep-tag I and Strep-tag II (44). Exploiting the improved accessibility of the C-terminal amino acids of the C-terminally truncated form, the chimeric gene encoding an S-layer fusion protein comprising the sequence of Bet v1, the major birch pollen allergen, was cloned and expressed in E. coli. The obtained fusion protein, rSbpA31-1068/Bet v1, will be used for preparing Bet v1-specific immunoglobulin E (IgE)-binding monolayers, as required for biochip development.
|
|
|---|
Other strains, plasmids, culture conditions, and DNA manipulations.
For cloning, E. coli TG1 was transformed with the plasmid pBluescript II KS(+) or pET28a. For expression, E. coli HMS174(DE3) was chosen as a host strain for derivatives of pET28a (Table 1) as described previously (41). E. coli was grown on Luria-Bertani medium (Gibco BRL Life Technologies) or on modified M9ZB medium (41) at 37°C. For selection of transformants harboring KS(+) or pET28a, kanamycin was added to the medium to a final concentration of 30 µg/ml. Chromosomal DNA of B. sphaericus CCM 2177 was prepared by using Genomic Tips 100 (Qiagen) according to the manufacturer's instructions. Digestion of DNA with restriction endonucleases, separation of DNA fragments by agarose gel electrophoresis, ligation of DNA fragments, and transformation procedures were performed as described previously (32). DNA fragments were recovered from agarose gels by using the Qiaex II Gel Extraction Kit (Qiagen).
|
View this table: [in a new window] |
TABLE 1. Plasmid pET28a with various derivatives of the sbpA gene inserted
|
![]() View larger version (18K): [in a new window] |
FIG. 2. Schematic drawing showing the four chromosomal DNA fragments from B. sphaericus CCM 2177 used for isolation of the sbpA gene by a PCR-based technique. RBS, ribosome binding site.
|
Cloning of the genes encoding rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1.
For PCR amplification of the sbpA gene with chromosomal DNA of B. sphaericus CCM 2177 as the template, the oligonucleotide primers sbpA28 (5'-CGC GGA TCC CAT ATG GCG CAA GTA AAC GAC TAT AAC AAA ATC-3') and sbpA29 (5'-CGC GGA TCC TTA TTT TGT AAT TGT TAC TGT TAA TTC AGC-3'), which introduced restriction sites (in boldface) for NdeI (at the 5' end of the coding sequence) and BamHI (at the 3' end), respectively, were constructed. For cloning, the gel-purified PCR fragment was inserted into the corresponding restrictions sites of plasmid pET28a, and the derivative pSbpA1 (Table 1) was established in E. coli TG1.
The genes encoding the SbpA derivatives rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I were amplified by PCR from chromosomal DNA of B. sphaericus CCM 2177 by using the oligonucleotide primer sbpA37 (forward primer for both genes) (5'-CGG AAT TCC ATG GCG CAA GTA AAC GAC TAT AAC AAA ATC-3') and sbpA39 (reverse primer for the gene encoding rSbpA/Strep-tag I) (5'-GA CCG CTC GAG TTA ACC ACC GAA CTG CGG GTG ACG CCA CGC ACC ACC TTT TGT AAT TGT TAC TGT TAA TTC AGC-3') or sbpA2a (reverse primer for the gene encoding rSbpA31-1068/Strep-tag I) (5'-GA CCG CTC GAG TTA ACC ACC GAA CTG CGG GTG ACG CCA CGC ACC ACC TTC TGA ATA TGC AGT AGT TGC TGC-3'). The primers sbpA39 and sbpA2a introduced the sequence of Strep-tag I (underlined) at the 3' end of the coding sequence of sbpA. For cloning, NcoI and XhoI restriction sites (boldface) were introduced during PCR at the 5' and 3' ends, respectively. The resulting PCR fragments were cloned into pET28a to generate the new plasmids pSbpA2 and pSbpA3 (Table 1).
To obtain the desired chimeric PCR product encoding the S-layer fusion protein rSbpA31-1068/Bet v1, overlap extension PCR (11) was applied. For amplification of the sbpA derivative encoding rSbpA31-1068, DNA isolated from whole cells of B. sphaericus CCM 2177 was used as a template and the oligonucleotide primers sbpA37 (5'-CGG AAT TCC ATG GCG CAA GTA AAC GAC TAT AAC AAA ATC-3') (primer 1) and sbpA6a (5'-GTA ATT GAA AAC ACC CAT ACC ACC TTC TGA ATA TGC AGT AGT TGC TGC C-3') (primer 2) were chosen. Primer 1 introduced a NcoI restriction site (boldface) at the 5' end of the coding sequence, and primer 2 contained an overlapping complementary Bet v1 gene sequence (underlined) at the 3' end. For PCR amplification of the Bet v1 gene from plasmid pMW175 (12), the nucleotide primers sbpA7a (5'-ACT ACT GCA TAT TCA GAA GGT GGT ATG GGT GTT TTC AAT TAC GAA ACT GAG-3') (primer 3) and spbA5a (5'-GAC CGC TCG AGT TAG TTG TAG GCA TCG GAG TGT G-3') (primer 4), which introduced a complementary sbpA overlap (underlined) at the 5' end and the restriction site XhoI (boldface) at the 3' end of the coding sequence, were used. In primers containing the overlapping sequences, the sequence encoding two glycine residues (GGT GGT) was introduced as a spacer between rSbpA31-1068 and Bet v1. For amplification of the chimeric gene encoding the fusion protein rSbpA31-1068/Bet v1, the gel-purified PCR products from the PCRs described above were used as templates together with primer 1 and primer 4. For cloning in pET28a, the obtained PCR product was used to generate the new plasmid pSbpA4 (Table 1).
Expression of rSbpA, rSbpA/Strep-tag I, rSpbA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1.
The plasmid stability test and heterologous expression in E. coli HMS174(DE3) were performed as described previously (17). Samples (1.5 ml) of the E. coli HMS174(DE3) cultures were taken 1 to 5 h after induction of expression of the sbpA gene or its derivatives. Preparation of biomass samples and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were carried out as described previously (17). For electron microscopic investigation, whole cells of E. coli HMS174(DE3) were fixed and embedded in Spurr resin and subjected to ultrathin sectioning according to procedures described previously (28). Immunoblotting with a polyclonal rabbit antiserum raised against the S-layer protein of B. sphaericus CCM 2177 was performed as described previously (8). The presence of Bet v1 epitopes was checked by immunoreactivity with BIP1, a monoclonal mouse anti-Bet v1 antibody (15). The presence of Strep-tag I was checked by dot blot assays. For this purpose, 5 µl of solutions containing 600 µg of either rSbpA/Strep-tag I or rSbpA31-1068/Strep-tag I per ml in 0.1 M Tris-buffered saline (TBS) were dried on a nitrocellulose membrane. After blocking with 3% bovine serum albumin (BSA) in 0.1 M TBS for 1 h at 20°C, the membrane was incubated with a polyclonal rabbit antiserum raised against the Strep-tag (IBA-Strep-tag Detection System) (diluted 1:2,000 in wash buffer [0.1% Tween 20 in 0.1 M TBS]) for 1 h at 20°C and washed three times. Incubation with anti-rabbit IgG-alkaline phosphatase (ALP) conjugate (Sigma) (diluted 1:4,000 in wash buffer) was done for 1 h at 20°C. After three further wash steps, detection was accomplished by treatment with 5-bromo-4-chloro-3-indolylphosphate and nitroblue tetrazolium chloride (Roche). In addition, a Strep-Tactin-ALP conjugate (IBA-Strep-tag Detection System) was used to detect the presence of Strep-tag I.
Isolation and purification of rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1.
Isolation of all rSbpA forms was performed as described previously (16). For purification, aliquots (120 mg) of the lyophilized recombinant S-layer protein forms were suspended in 5 ml of 2 M guanidine hydrochloride (GHCl) in 50 mM Tris-HCl buffer (pH 7.2). After centrifugation at 16,000 x g for 5 min at 4°C, the supernatants were filtered through a 0.45-µm-pore-size RC membrane (Minisart RC 25), and the clear solutions were subjected to gel permeation chromatography (GPC) using a Superdex 200 column (Pharmacia) equilibrated in 2 M GHCl in 50 mM Tris-HCl buffer (pH 7.2) for separation. Fractions containing S-layer protein were pooled, dialyzed against distilled water for 18 h at 4°C, lyophilized, and stored at -20°C. In addition, rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I were purified with a Ready-to-Use Strep-Tactin Sepharose column (IBA-Strep-tag Purification System). The purities of rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1 were finally checked by SDS-PAGE.
Self-assembly properties of rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1 and recrystallization of soluble rSbpA forms on poly-L-lysine-coated electron microscopy (EM) grids
To investigate the ability of the various rSbpA forms to self-assemble, 3 mg of the GPC-purified rSbpA forms was dissolved in 1 ml of 5 M GHCl in 50 mM Tris-HCl buffer (pH 7.2) and the solutions were dialyzed against 10 mM CaCl2 in distilled water for 18 h at 4°C. Negative staining of the suspensions and freeze-drying were performed as described previously (29). To investigate the ability of soluble (monomeric and/or oligomeric) rSbpA to recrystallize on poly-L-lysine-coated copper grids, the GHCl extracts were dialyzed against distilled water for 18 h at 4°C. After centrifugation for 5 min at 16,000 x g, the clear supernatants containing nonassembled S-layer protein were incubated with poly-L-lysine (Sigma P2636)-coated copper grids by procedures described previously (29).
Recrystallization of rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1 on peptidoglycan-containing sacculi and studies on accessibility of the fused Strep-tag I or Bet v1 sequence in the square S-layer lattice
In all experiments rSbpA, rSbpA/Strep-tag I, rSbpA31-1068/Strep-tag I, and rSbpA31-1068/Bet v1 were recrystallized on native peptidoglycan-containing sacculi of B. sphaericus CCM 2177 according to the protocol described previously (7), except that samples were dialyzed against 10 mM CaCl2. Peptidoglycan-containing sacculi completely covered with outer and inner S-layer lattices were termed recrystallization products. For investigating the accessibility of Strep-tag I on the outer surface of the S-layer lattice, recrystallization products prepared with rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I (each corresponding to 1 mg of S-layer protein) were incubated with recombinant streptavidin (Sigma S0677) (500 µg/ml in 50 mM Tris-HCl buffer, pH 8.0) for 30 min at 20°C and washed twice with buffer. Samples were then prepared for SDS-PAGE, and bound streptavidin was visualized on immunoblots after incubation with a polyclonal antiserum raised against streptavidin (Sigma) (1:5,000 in 3% BSA in 0.15 M TBS buffer) and anti-rabbit IgG-ALP conjugate (Sigma) (diluted 1:4,000 in 3% BSA in 0.15 M TBS). The accessibility of Strep-tag I was derived from the binding capacity of recrystallization products for streptavidin.
For investigation of the functionality and accessibility of the Bet v1 portion at the C terminus of rSbpA31-1068/Bet v1, recrystallization products were incubated with the monoclonal mouse antibody BIP1. After centrifugation of the suspension at 16,000 x g at 4°C for 20 min and five washing steps with 0.15 M TBS, the pellet was suspended in 40 µl of anti-mouse IgG-colloidal gold conjugate (Amersham) and incubated for 60 min at 20°C. Unbound gold-labeled antibody was removed by centrifugation under the conditions described above and three washing steps with 0.15 M TBS. The pellet was resuspended in 40 µl of distilled water and subjected to negative staining. As a control, the same procedure was carried out with recrystallization products prepared with rSbpA recrystallized on peptidoglycan-containing sacculi.
|
|
|---|
The size of the mRNA transcribed from the sbpA gene was determined by Northern blotting using a DNA probe comprising the coding region of the sbpA gene. The probe detected a transcript of approximately 4.45 kb (Fig. 3), which was in good agreement with the size of the sbpA gene.
![]() View larger version (37K): [in a new window] |
FIG. 3. Northern blot of total RNA isolated from B. sphaericus CCM 2177 cells harvested in the exponential growth phase. The DNA probe comprising the coding region of the sbpA gene detected a transcript of approximately 4.45 kb (arrow). The size of the sbpA mRNA was estimated by using the DIG-dUTP-labeled RNA Molecular Weight Marker II (Boehringer Mannheim).
|
![]() View larger version (77K): [in a new window] |
FIG. 4. Lanes 1 to 5, SDS-PAGE pattern of SDS-extracted whole cells of E. coli HMS174(DE3) harboring the pET28a/sbpA gene construct before (lane 1) and 1, 2, 3, and 5 h after (lanes 2 to 5, respectively) induction of sbpA expression. Lane 6, rSbpA purified by GPC. Lanes 7 and 8, immunoblot analysis using a polyclonal rabbit antiserum raised against the whole S-layer protein of B. sphaericus CCM 2177. In lanes 7 and 8, SDS extracts of the S-layer protein from B. sphaericus CCM 2177 or purified rSbpA were applied.
|
![]() View larger version (75K): [in a new window] |
FIG. 5. Electron micrograph of an ultrathin-section preparation of E. coli HMS174(DE3) induced to express the sbpA gene. Inclusion body-like structures are indicated by arrows. Bar, 400 nm.
|
Isolation and purification of rSbpA from host cells and characterization of its properties.
As derived from SDS-PAGE, rSbpA had accumulated in the insoluble fraction of the lysed E. coli HMS174(DE3) cells (data not shown). After purification of rSbpA by GPC, a single protein band with an apparent molecular mass of 127,000 Da was detected on SDS gels (Fig. 4, lane 6). By applying the isolation and purification procedure described above, about 120 mg of GPC-purified rSbpA was obtained from 5 g (wet pellet) of biomass from E. coli HMS174(DE3) harvested 5 h after induction of sbpA expression. Immunoblotting using the polyclonal rabbit antiserum raised against the S-layer protein of B. sphaericus CCM 2177 revealed a strong cross-reaction with the additional high-molecular-mass protein band representing purified rSbpA (Fig. 4, lane 8). The S-layer protein isolated from B. sphaericus CCM 2177 taken as a control showed a comparably strong cross-reaction with the polyclonal rabbit antiserum (Fig. 4, lane 7). When purified rSbpA was subjected to N-terminal sequencing, the first five amino acids (AQVND) were identical to those of the mature S-layer protein of B. sphaericus CCM 2177. Together with the data from SDS-PAGE and immunoblotting, these findings indicated that the sbpA gene encodes the S-layer protein SbpA of B. sphaericus CCM 2177.
Cloning and expression of the genes encoding rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I and characterization of their properties.
The PCR products encoding the SbpA derivatives rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I, ligated into the pET28a vector, were cloned in E. coli TG1 and expressed in E. coli HMS174(DE3). Whole cells of E. coli HMS174(DE3) induced to express these genes showed additional protein bands with apparent molecular masses of 127,000 or 111,000 Da on SDS gels (Fig. 6a). N-terminal sequencing of isolated and purified rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I confirmed that the first five amino acids of both SbpA derivatives were identical to those of the S-layer protein of B. sphaericus CCM 2177. The presence of the SbpA-specific part in both rSbpA forms was confirmed by immunoblotting using the polyclonal rabbit antiserum raised against the S-layer protein of B. sphaericus CCM 2177 (data not shown). For investigation of the presence of Strep-tag I, dot blot assays with rSbpA/Strep-tag I and rSbpA31-1068/Strep-tag I, purified via a Ready-to-Use Strep-Tactin Sepharose column, were performed. Independent of the use of a polyclonal rabbit antiserum raised against the Strep-tag (not shown) or the use of Strep-Tactin-ALP (Fig. 6b), rSbpA31-1068/Strep-tag I (Fig. 6b, spot 3) gave a significantly stronger reaction than rSbpA/Strep-tag I (Fig. 6b, spot 2), indicating a clearly improved accessibility of Strep-tag I in the C-terminally truncated form. The formation of self-assembly products and the ability to recrystallize on native peptidoglycan-containing sacculi demonstrated that neither the deletion of 200 C-terminal amino acids in rSbpA31-1068/Strep-tag I nor the presence of Strep-tag I in both rSbpA forms interfered with the self-assembly and cell wall binding properties.
![]() View larger version (45K): [in a new window] |
FIG. 6. (a) SDS-PAGE of GPC-purified SbpA derivatives. Lane 1, rSbpA/Strep-tag I; lane 2, rSbpA31-1068/Strep-tag I. (b) Dot blot assays indicating the accessibility of Strep-tag I to Strep-Tactin-ALP in the soluble S-layer protein fractions. Spot 1, rSbpA; spot 2, rSbpA/Strep-tag I; spot 3, rSbpA31-1068/Strep-tag I. (c) Immunoblot analysis for detection of recombinant streptavidin bound by recrystallization products prepared with rSbpA (lane 1), rSbpA/Strep-tag I (lane 2), and rSbpA31-1068/Strep-tag I (lane 3). Monomers of core streptavidin show a molecular mass of 13,000 Da on SDS gels. In the case of streptavidin, low nonspecific adsorption was observed for the square S-layer lattice formed by rSbpA.
|
Cloning and expression of rSbpA31-1068/Bet v1.
A PCR product comprising the chimeric gene encoding the S-layer fusion protein rSbpA31-1068/Bet v1 obtained by PCR using primers 1 and 4 was ligated into the pET28a vector. The plasmid was first cloned in E. coli TG1 and then established in E. coli HMS174(DE3) for expression. As shown by SDS-PAGE (Fig. 7), in comparison to uninduced E. coli HMS174(DE3) cells (Fig. 7, lane 1), an additional high-molecular-mass protein band was observed in whole cells from E. coli HMS174(DE3) cells induced to express the gene encoding rSbpA31-1068/Bet v1 (Fig. 7, lanes 2, 3, and 4). This additional protein band had an apparent molecular mass of 127,000 Da. On immunoblots, a cross-reaction was observed between the high-molecular-mass protein band and the polyclonal rabbit antiserum raised against the S-layer protein of B. sphaericus CCM 2177 (Fig. 7, lane 7), as well as with the monoclonal mouse antibody BIP1 recognizing epitopes of Bet v1 (Fig. 7, lane 9). The S-layer protein of B. sphaericus CCM 2177, which was used as a control, showed a strong cross-reaction with the polyclonal rabbit antiserum (Fig. 7, lane 6) and no reaction with BIP1 (Fig. 7, lane 8). E. coli HMS174(DE3) cells containing the plain pET28a plasmid showed a cross-reaction neither with the polyclonal rabbit antiserum raised against the S-layer protein SbpA nor with the monoclonal mouse antibody BIP1 recognizing Bet v1 (data not shown). Ultrathin sections of whole cells from E. coli HMS174(DE3) induced to express the gene encoding rSbpA31-1068/Bet v1 revealed the presence of inclusion bodies in the cytoplasm of the host cells (data not shown). N-terminal sequencing of the purified rSbpA31-1068/Bet v1 confirmed that the first five amino acids (AQVND) were identical to those of the S-layer protein of B. sphaericus CCM 2177. Isolation and purification of the S-layer fusion protein from the host cells were performed as described for rSbpA, leading to a single major protein band with a molecular mass of 127,000 Da on SDS gels (Fig. 7, lane 5).
![]() View larger version (57K): [in a new window] |
FIG. 7. Lanes 1 to 4, SDS-PAGE pattern of SDS-extracted whole cells of E. coli HMS174(DE3) containing pET28a with the sbpA derivative encoding rSbpA31-1068/Bet v1 before (lane 1) and 1, 3, and 5 h after (lanes 2 to 4, respectively) induction of S-layer fusion protein expression. Lane 5, rSbpA31-1068/Bet v1 purified by GPC. Lanes 6 and 7, immunoblot analysis using a polyclonal rabbit antiserum raised against SbpA; SDS extracts of the S-layer protein from B. sphaericus CCM 2177 or rSbpA31-1068/Bet v1 were applied. Lanes 8 and 9, immunoblot analysis using the monoclonal antibody BIP1 raised against Bet v1; the samples corresponding to lanes 6 and 7 were applied.
|
![]() View larger version (162K): [in a new window] |
FIG. 8. Electron micrographs of negatively stained preparations. (a) Self-assembly properties of rSbpA. (b) Ability of rSbpA to recrystallize on poly-L-lysine-coated EM grids. (c) Formation of the square S-layer lattice by rSbpA31-1068/Bet v1 on peptidoglycan-containing sacculi of B. sphaericus CCM 2177. (d) Immunogold labeling of recrystallization products obtained with rSbpA31-1068/Bet v1 using the Bet v1-specific monoclonal antibody BIP1. Bars, 200 nm.
|
Immunogold labeling of recrystallization products obtained with rSbpA31-1068/Bet v1.
To investigate the location and functionality of the fused Bet v1 sequence, rSbpA31-1068/Bet v1 was recrystallized on peptidoglycan-containing sacculi of B. sphaericus CCM 2177 (Fig. 8c) and subsequently labeled with BIP1. The bound antibody was visualized with an anti-mouse IgG-colloidal gold conjugate. The dense labeling of recrystallization products provided evidence for the functionality of the fused Bet v1 portion and its location on the outer surface of the S-layer lattice (Fig. 8d). Recrystallization products prepared with rSbpA remained unlabeled (data not shown).
|
|
|---|
The amino acid composition of SbpA indicated a high content of acidic and hydrophobic amino acids; a low content of histidine, arginine, and methionine; and no cysteine. This composition is characteristic of S-layer proteins from Bacillaceae (35). Prediction of the secondary structure from sequence data as described previously (31) indicated the concentration of
-helices in the N-terminal part, whereas the middle and C-terminal parts are dominated by loops and short ß-strands.
The N-terminal part of SbpA, with a calculated pI of 4.49, comprises three typical SLH motifs, each consisting of 50 amino acids. In a previous study, the N-terminal part of SbpA was found to be involved in anchoring the S-layer subunits via a pyruvylated SCWP to the rigid cell wall layer (13). Mesnage et al. (25) demonstrated that the mechanism of anchoring between SLH motifs and pyruvylated peptidoglycan-associated wall polymers is widespread among prokaryotes and has been conserved during evolution. In general, SLH motifs occur in a single copy or in two or three copies either at the N-terminal part of many S-layer proteins or at the C-terminal ends of cell-associated exoenzymes and other exoproteins of gram-positive bacteria (Table 2) (9, 22, 23). Comparison of the pIs of the SLH domains generally revealed an acidic nature, with pIs comparable to those of the remaining parts of the sequences. However, a few exceptions with calculated pIs of >7 were found, which are the SLH domains of the S-layer protein SbsB of Bacillus stearothermophilus PV72/p2 (18), the hexagonal wall protein HWP from Bacillus brevis HPD31 (43), and the cellulosome-anchoring protein and cell surface glycoprotein 2 of Clostridium thermocellum NCIMB 10682 (10) (Table 2). In these cell-associated exoproteins, the basic pIs of the SLH domains are in contrast to the acidic pIs of the remaining part of the proteins. In the case of SbpA, the acidic nature of the SLH domain may explain why bivalent cations are required for binding of the S-layer subunits to the rigid cell wall layer (13). On the other hand, neither monovalent nor bivalent cations are necessary for binding of the S-layer proteins with basic N-terminal parts, such as SbsB (pI 8.67), to the rigid cell wall layer (30).
|
View this table: [in a new window] |
TABLE 2. Comparison of SLH domain-containing cell-associated exoproteins from gram-positive bacteria
|
Thus, one of the goals in the present study was to identify amino acid positions at the C-terminal part of SbpA to which functional sequences can be fused and which after folding of both protein moieties remain located on the outer surface of the S-layer lattice. To generate oriented monolayers and to evaluate the surface accessibility of the introduced functional sequences, all rSbpA forms were recrystallized on peptidoglycan-containing sacculi. Strep-tag I linked to the C-terminal end of rSbpA revealed, even in the soluble form of the full-length S-layer protein, a limited accessibility for macromolecules, such as antibodies or the Strep-Tactin-ALP-conjugate. The accessibility of Strep-tag I could be significantly increased when it was linked to the C-terminally truncated form rSbpA31-1068. Despite the deletion of 200 C-terminal amino acids, rSbpA31-1068/Strep-tag I had retained the ability to self-assemble and to recrystallize on peptidoglycan-containing sacculi into the square S-layer lattice, and Strep-tag I remained accessible on the outer S-layer surface for macromolecule binding.
Due to these properties, the C-terminally truncated SbpA form was selected as the base form for construction of the S-layer fusion protein comprising the Bet v1 sequence, which was produced with the final aim of building up highly ordered Bet v1-specific protein lattices on solid supports. Both features, namely, (i) the ability of rSbpA31-1068/Bet v1 to bind to native peptidoglycan-containing sacculi and to recrystallize into the square lattice structure and (ii) the formation of self-assembly products in suspension, confirmed the functionality of the S-layer protein moiety. Evidence for the location of the fused Bet v1 sequence on the outer surface of the S-layer lattice and proof of its functionality were provided by the high binding density observed for the monoclonal mouse antibody BIP1.
In various other S-layer fusion proteins described so far, only the cell wall-targeting domains such as the three SLH motifs have been exploited. For this purpose, the chimeric genes encoding the sequences of the SLH domains of the S-layer protein Sap or EA1 of Bacillus anthracis and levansucrase of Bacillus subtilis were cloned in B. anthracis (26). The SLH motifs were also incorporated into the fusion protein SLH-Tox, carrying fragment C of the tetanus toxoid of Clostridium tetanii (27). Another example is the green fluorescence-SAC fusion protein, containing the C-terminal cell wall-targeting domain of Lactobacillus acidophilus ATCC 4536 (40). Because of the absence of those domains required for self-assembly, none of these S-layer fusion proteins formed a regularly structured protein lattice.
The example of the rSbpA31-1068/Bet v1 fusion protein demonstrated that functional, regularly structured protein lattices can be built up with S-layer fusion proteins. In such protein lattices, the functional sequences are aligned at a predefined distance in the nanometer range on the outermost surface of the S-layer lattice and therefore remain available for further binding reactions. These specific features imply a considerable application potential for biochip development as required in proteomics or genomics. In the present state of the rSbpA31-1068/Bet v1 monolayer, the density of the fused Bet v1 sequence is determined by the intrinsic properties of the S-layer protein moiety and the resulting center-to-center spacing of the morphological units.
Plasmid pMW175 was kindly provided by BIOMAY, Linz, Austria.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»